Health, Longevity & Biohacking
Creator of NMR lipid testing warns LabCorp’s Vanta analysers may soon fail
Peter Attia Drive
402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
What was said
""what people don't know is that at some point in the future, maybe sooner rather than later, these Vanta analyzers, first generation, only generation, [laughter] uh, are going to cease to function.""
Jim Otvos, founder of Liposcience and developer of NMR-based lipoprotein testing, says the Vanta NMR analysers used for LabCorp’s NMR LipoProfile are ageing and could stop working. He argues the field needs an in‑vitro diagnostics (IVD) company to take on the technology so NMR-based assays can continue and scale beyond LabCorp’s current footprint.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Programme
- Peter Attia Drive
- Episode
- 402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
- Clip time
- 1:14:36
- Original source
- Watch the source segment →
From this episode
Peter Attia Drive